Product Code: GVR-4-68039-953-2
Medical Injection Molded Plastic Market Growth & Trends:
The global medical injection molded plastic market size is anticipated to reach USD 37.61 billion by 2030, according to a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 4.3% from 2023 to 2030. Increasing healthcare investments across emerging nations is expected to drive the market. The global healthcare sector continues to expand at a faster rate than the overall economy, thereby contributing to the growth of medical injection molded plastics.
Between 2002 and 2022, global healthcare spending, in real terms, increased by approximately 4.0% per year, while the economy grew by 3.0% annually. This significant increase in healthcare spending was particularly notable in a group of 42 countries that experienced rapid economic growth. On average, real healthcare spending per capita grew 2.2 times, and its share of GDP increased by 0.6 percentage points. In most cases, healthcare spending outpaced GDP growth between 2002 and 2022.
Medical injection molded plastics are gaining importance in the manufacturing of medical devices and medical products on account of their properties such as durability, temperature resistance, corrosion resistance, and ability to withstand wear & tear. Increasing demand for injection molded plastics in medical applications, such as syringes, inhalation masks, catheters, and other surgical tools, is expected to further drive the market growth over the forecast period.
Medical Injection Molded Plastic Market Report Highlights:
- Based on product, the acrylonitrile butadiene styrene (ABS) segment is anticipated to grow at a CAGR of 4.5% during the forecast period. ABS finds applications in tendon prostheses, non-absorbable sutures, cleaning equipment, drug delivery systems, and tracheal tubes due to its high-impact resistance and durability
- Based on application, the implants segment is expected to grow at a CAGR of 4.3% over the forecast period. Various implantable medical devices including pacemaker casing and joint replacements, use biocompatible injection molded plastics to minimize adverse reactions in the body
- Mergers, acquisitions, strategic partnerships, capacity expansions, and the introduction of new products are the major strategies undertaken by the major players to strengthen their market presence. In June 2020, Eastman Chemical Company announced that it would be expanding and reinforcing its partnership with IMCD Group to distribute its plastics in different markets
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Medical Injection Molded Plastic Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.5. Market Dynamics
- 3.5.1. Market driver analysis
- 3.5.2. Market restraint analysis
- 3.5.3. Industry opportunities & challenges
- 3.6. Medical Injection Molded Plastic Market Analysis Tools
- 3.6.1. Industry analysis - Porter's
- 3.6.1.1. Supplier power
- 3.6.1.2. Buyer power
- 3.6.1.3. Substitution threat
- 3.6.1.4. Threat of new entrant
- 3.6.1.5. Competitive rivalry
- 3.6.2. PESTEL analysis
- 3.6.2.1. Political landscape
- 3.6.2.2. Technological landscape
- 3.6.2.3. Economic landscape
- 3.6.2.4. Social landscape
- 3.6.2.5. Environmental landscape
- 3.6.2.6. Legal landscape
Chapter 4. Supplier Portfolio Analysis
- 4.1. List of Suppliers
- 4.2. Kraljic Matrix
- 4.3. Sourcing Best Practices
- 4.4. Negotiation Strategies
Chapter 5. Medical Injection Molded Plastic: Product Estimates & Trend Analysis
- 5.1. Medical Injection Molded Plastic Market: Key Takeaways
- 5.2. Medical Injection Molded Plastic Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Polypropylene (PP)
- 5.3.1. Polypropylene (PP) market estimates and forecasts, 2018 to 2030 (USD Million, Kilo Tons)
- 5.4. Acrylonitrile Butadiene Styrene (ABS)
- 5.4.1. Acrylonitrile butadiene styrene (ABS) market estimates and forecasts, 2018 to 2030 (USD Million, Kilo Tons)
- 5.5. Polyethylene (PE)
- 5.5.1. Polyethylene (PE) market estimates and forecasts, 2018 to 2030 (USD Million, Kilo Tons)
- 5.6. Polystyrene (PS)
- 5.6.1. Polystyrene (PS) market estimates and forecasts, 2018 to 2030 (USD Million, Kilo Tons)
- 5.7. Polycarbonate (PC)
- 5.7.1. Polycarbonate (PC) market estimates and forecasts, 2018 to 2030 (USD Million, Kilo Tons)
- 5.8. Others
- 5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million, Kilo Tons)
Chapter 6. Medical Injection Molded Plastic: Application Estimates & Trend Analysis
- 6.1. Medical Injection Molded Plastic Market: Key Takeaways
- 6.2. Medical Injection Molded Plastic Market: Movement & Market Share Analysis, 2022 & 2030
- 6.3. Medical Components
- 6.3.1. Packaging market estimates and forecasts, 2018 to 2030 (USD Million, Kilo Tons)
- 6.4. Implants
- 6.4.1. Implants market estimates and forecasts, 2018 to 2030 (USD Million, Kilo Tons)
- 6.5. Cleanroom Supplies
- 6.5.1. Cleanroom supplies market estimates and forecasts, 2018 to 2030 (USD Million, Kilo Tons)
- 6.6. Mobility Aids
- 6.6.1. Mobility aids market estimates and forecasts, 2018 to 2030 (USD Million, Kilo Tons)
- 6.7. Others
- 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million, Kilo Tons)
Chapter 7. Medical Injection Molded Plastic Market: Regional Estimates & Trend Analysis
- 7.1. Regional Outlook
- 7.2. Medical Injection Molded Plastic Market by Region: Key Takeaway
- 7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.3.2. U.S.
- 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.3.3. Canada
- 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.3.4. Mexico
- 7.3.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.4.2. Germany
- 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.4.3. France
- 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.4.4. Italy
- 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.4.5. Spain
- 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.4.6. Poland
- 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.4.7. Netherlands
- 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.5.2. China
- 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.5.3. India
- 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.5.4. Australia
- 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.5.5. Thailand
- 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.5.6. South Korea
- 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.5.7. Malaysia
- 7.5.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.5.8. Indonesia
- 7.5.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.6. Central & South America
- 7.6.1. Brazil
- 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.6.2. Argentina
- 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.7. MEA
- 7.7.1. Saudi Arabia
- 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.7.2. South Africa
- 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
- 7.7.3. UAE
- 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million, Volume, Kilo Tons)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Market Participant Categorization
- 8.2.1. Dow, Inc.
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. SABIC
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Eastman Chemical Company
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Celanese Corporation
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Covestro AG
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Rutland Plastics
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Evonik Industries AG
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. Sumitomo Chemical Co., Ltd.
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Arkema
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. INEOS Group
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives